Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis

Area of Science:

• Molecular Biology
• Cancer Research
• Protein Interactions

Background:

• p53 protein is crucial for tumor suppression, acting via DNA binding and transcription activation.
• Mutant p53 and ΔNp73 isoforms can form complexes with TAp73, potentially inhibiting its function.
• Some p53 isoforms are known to complex with wild-type p53 (wtp53) and inhibit its tumor suppressor activities.

Purpose of the Study:

• To investigate whether p53 isoforms can form complexes with TAp73 isoforms.
• To determine if p53 isoforms can act as dominant-negative inhibitors of TAp73.
• To elucidate how p53 isoforms modulate TAp73 functions, impacting tumorigenesis.

Main Methods:

• Co-immunoprecipitation assays were employed to study complex formation between p53 and p73 isoforms.
• Transactivation assays were used to assess the functional impact of these interactions on TAp73β.
• Protein half-life determination was performed for various p53 isoforms.

Main Results:

• All six tested p53 isoforms formed complexes with TAp73β; only Δ133p53α/β/γ isoforms complexed with TAp73α.
• p53 isoforms inhibited TAp73β transactivation differently, depending on the isoform and promoter.
• Δ133p53α and Δ133p53β most effectively inhibited TAp73β's apoptotic activity, while p53β augmented it.
• Half-life analysis revealed p53γ as the shortest and Δ133p53γ as the longest-lived isoform.
• Only Δ133p53α, Δ133p53β, and Δ40p53α stabilized TAp73β upon complex formation.

Conclusions:

• p53 isoforms exhibit diverse interaction capabilities with TAp73 isoforms, affecting TAp73's transcriptional and apoptotic functions.
• Specific p53 isoforms can act as dominant-negative regulators of TAp73, with varying efficiencies.
• Understanding these p53/p73 isoform interactions offers critical insights into p73 function modulation in cancer.